Who is sponsoring NCT03433170?

NCT03433170 is sponsored by Fundacion Clinica Valle del Lili.

What condition does NCT03433170 study?

NCT03433170 studies Anterior Cruciate Ligament Injury.

Is NCT03433170 still recruiting?

NCT03433170 is currently completed. Last updated 19 September 2025.

Last reviewed 2025-09-19 · How we verify

NCT03433170

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Quadrupled Semitendinosus Graft in Anterior Cruciate Ligament Reconstruction

Completed NA Last updated 19 September 2025

What this trial tests

NA trial testing Quadrupled semitendinosus graft in Anterior Cruciate Ligament Injury in 42 participants. Completed in 31 July 2022.

Timeline

20 January 2018

Primary endpoint
30 June 2022

31 July 2022

Quick facts

Lead sponsor	Fundacion Clinica Valle del Lili
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	42
Start date	20 January 2018
Primary completion	30 June 2022
Estimated completion	31 July 2022
Sites	1 location across Colombia

Drugs / interventions tested

Quadrupled semitendinosus graft
ST-Gracilis graft

Conditions studied

Anterior Cruciate Ligament Injury — all drugs for Anterior Cruciate Ligament Injury →

Sponsor

Fundacion Clinica Valle del Lili

Who can join

15 and older, any sex, with Anterior Cruciate Ligament Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Randomized controlled trial comparing reconstruction of anterior cruciate ligament (ACL) with autologous quadrupled semitendinosus graft or with both semitendinosus and gracilis. It is intended to specially evaluate if by using only the semitendinosus (ST) tendon, the strength of the limb for hamstrings is affected different compared to using both gracilis and ST.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Similar results with quadrupled semitendinosus and semitendinosus-gracilis graft in anterior cruciate ligament reconstruction: A randomised controlled trial with 2-year follow-up.
Martinez-Cano JP, Gallego A, Cuadros J, Ibarra L, et al · · 2025 · PMID 41018256 · DOI 10.1002/jeo2.70399

Verify or expand the search:

Other recruiting trials for Anterior Cruciate Ligament Injury

Currently open trials in the same condition.

NCT06357091 — ACL Reconstruction With Shark Screw® or Biocomposite-interference Screws · NA · recruiting
NCT05527171 — Virtual Reality Mindfulness Meditation After ACL Reconstruction · NA · recruiting
NCT03935750 — STABILITY 2: Anterior Cruciate Ligament Reconstruction +/- Lateral Tenodesis With Patellar vs Quad Tendon · NA · active not recruiting
NCT03348995 — The BEAR III Trial for Bridge-Enhanced ACL (Anterior Cruciate Ligament) Restoration · NA · active not recruiting

Other Fundacion Clinica Valle del Lili trials

Trials by the same sponsor.

NCT06875791 — Safety and Efficacy Trial of TV5M01 for Radiation-Induced Mucositis in Head and Neck Cancer Patients. · Phase 1, PHASE2 · not yet recruiting
NCT06843265 — Outcomes and Perceptions of the Implementation of the JADA Device in a Stage II Postpartum Hemorrhage Management Protoco · NA · not yet recruiting
NCT06620432 — High Vs. Low Segmental Hysterotomy: Impact on Uterine Wall Defects Post-Cesarean · NA · not yet recruiting
NCT06086080 — Non-operative Treatment in First-time Patellar Dislocation · NA · recruiting
NCT05922397 — Placenta Accreta Spectrum Topographic Classification · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03433170 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fundacion Clinica Valle del Lili
Last refreshed: 19 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03433170.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing